Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

Timo Mäkikallio; Niels R Holm; Mitchell Lindsay; Mark S Spence; Andrejs Erglis; Ian B A Menown; Thor Trovik; Markku Eskola; Hannu Romppanen; Thomas Kellerth; Jan Ravkilde; Lisette O Jensen; Gintaras Kalinauskas; Rikard B A Linder; Markku Pentikainen; Anders Hervold; Adrian Banning; Azfar Zaman; Jamen Cotton; Erlend Eriksen; Sulev Margus; Henrik T Sørensen; Per H Nielsen; Matti Niemelä; Kari Kervinen; Jens F Lassen; Michael Maeng; Keith Oldroyd; Geoff Berg; Simon J Walsh; Colm G Hanratty; Indulis Kumsars; Peteris Stradins; Terje K Steigen; Ole Fröbert; Alastair N J Graham; Petter C Endresen; Olli Kajander; Uday Trivedi; Juha Hartikainen; Vesa Anttila; David Hildick-Smith; Leif Thuesen; Evald H Christiansen; NOBLE study investigators

doi:10.1016/S0140-6736(16)32052-9

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

Timo Mäkikallio, Niels R Holm, Mitchell Lindsay, Mark S Spence, Andrejs Erglis, Ian B A Menown, Thor Trovik, Markku Eskola, Hannu Romppanen, Thomas Kellerth, Jan Ravkilde, Lisette O Jensen, Gintaras Kalinauskas, Rikard B A Linder, Markku Pentikainen, Anders Hervold, Adrian Banning, Azfar Zaman, Jamen Cotton, Erlend EriksenSulev Margus, Henrik T Sørensen, Per H Nielsen, Matti Niemelä, Kari Kervinen, Jens F Lassen, Michael Maeng, Keith Oldroyd, Geoff Berg, Simon J Walsh, Colm G Hanratty, Indulis Kumsars, Peteris Stradins, Terje K Steigen, Ole Fröbert, Alastair N J Graham, Petter C Endresen, Olli Kajander, Uday Trivedi, Juha Hartikainen, Vesa Anttila, David Hildick-Smith, Leif Thuesen, Evald H Christiansen, NOBLE study investigators

Research output: Contribution to journal › Journal article › Research › peer-review

619 Citations (Scopus)

Original language	English
Journal	The Lancet
Volume	388
Issue number	10061
Pages (from-to)	2743-2752
Number of pages	10
ISSN	0140-6736
DOIs	https://doi.org/10.1016/S0140-6736(16)32052-9
Publication status	Published - 2016

Access to Document

10.1016/S0140-6736(16)32052-9

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Mäkikallio, T., Holm, N. R., Lindsay, M., Spence, M. S., Erglis, A., Menown, I. B. A., Trovik, T., Eskola, M., Romppanen, H., Kellerth, T., Ravkilde, J., Jensen, L. O., Kalinauskas, G., Linder, R. B. A., Pentikainen, M., Hervold, A., Banning, A., Zaman, A., Cotton, J., ... NOBLE study investigators (2016). Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. The Lancet, 388(10061), 2743-2752. https://doi.org/10.1016/S0140-6736(16)32052-9

@article{f488eca93b934dc39eb5b987ac41befc,

title = "Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial",

author = "Timo M{\"a}kikallio and Holm, {Niels R} and Mitchell Lindsay and Spence, {Mark S} and Andrejs Erglis and Menown, {Ian B A} and Thor Trovik and Markku Eskola and Hannu Romppanen and Thomas Kellerth and Jan Ravkilde and Jensen, {Lisette O} and Gintaras Kalinauskas and Linder, {Rikard B A} and Markku Pentikainen and Anders Hervold and Adrian Banning and Azfar Zaman and Jamen Cotton and Erlend Eriksen and Sulev Margus and S{\o}rensen, {Henrik T} and Nielsen, {Per H} and Matti Niemel{\"a} and Kari Kervinen and Lassen, {Jens F} and Michael Maeng and Keith Oldroyd and Geoff Berg and Walsh, {Simon J} and Hanratty, {Colm G} and Indulis Kumsars and Peteris Stradins and Steigen, {Terje K} and Ole Fr{\"o}bert and Graham, {Alastair N J} and Endresen, {Petter C} and Matthias Corbascio and Olli Kajander and Uday Trivedi and Juha Hartikainen and Vesa Anttila and David Hildick-Smith and Leif Thuesen and Christiansen, {Evald H} and {NOBLE study investigators} and Jan Ravkilde and Leif Thuesen and Andreasen, {Jan Jesper} and Jens Aar{\o}e",

year = "2016",

doi = "10.1016/S0140-6736(16)32052-9",

language = "English",

volume = "388",

pages = "2743--2752",

journal = "The Lancet",

issn = "0140-6736",

publisher = "TheLancet Publishing Group",

number = "10061",

}

Mäkikallio, T, Holm, NR, Lindsay, M, Spence, MS, Erglis, A, Menown, IBA, Trovik, T, Eskola, M, Romppanen, H, Kellerth, T, Ravkilde, J, Jensen, LO, Kalinauskas, G, Linder, RBA, Pentikainen, M, Hervold, A, Banning, A, Zaman, A, Cotton, J, Eriksen, E, Margus, S, Sørensen, HT, Nielsen, PH, Niemelä, M, Kervinen, K, Lassen, JF, Maeng, M, Oldroyd, K, Berg, G, Walsh, SJ, Hanratty, CG, Kumsars, I, Stradins, P, Steigen, TK, Fröbert, O, Graham, ANJ, Endresen, PC, Kajander, O, Trivedi, U, Hartikainen, J, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, EH & NOBLE study investigators 2016, 'Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial', The Lancet, vol. 388, no. 10061, pp. 2743-2752. https://doi.org/10.1016/S0140-6736(16)32052-9

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. / Mäkikallio, Timo; Holm, Niels R; Lindsay, Mitchell et al.
In: The Lancet, Vol. 388, No. 10061, 2016, p. 2743-2752.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE)

T2 - a prospective, randomised, open-label, non-inferiority trial

AU - Mäkikallio, Timo

AU - Holm, Niels R

AU - Lindsay, Mitchell

AU - Spence, Mark S

AU - Erglis, Andrejs

AU - Menown, Ian B A

AU - Trovik, Thor

AU - Eskola, Markku

AU - Romppanen, Hannu

AU - Kellerth, Thomas

AU - Ravkilde, Jan

AU - Jensen, Lisette O

AU - Kalinauskas, Gintaras

AU - Linder, Rikard B A

AU - Pentikainen, Markku

AU - Hervold, Anders

AU - Banning, Adrian

AU - Zaman, Azfar

AU - Cotton, Jamen

AU - Eriksen, Erlend

AU - Margus, Sulev

AU - Sørensen, Henrik T

AU - Nielsen, Per H

AU - Niemelä, Matti

AU - Kervinen, Kari

AU - Lassen, Jens F

AU - Maeng, Michael

AU - Oldroyd, Keith

AU - Berg, Geoff

AU - Walsh, Simon J

AU - Hanratty, Colm G

AU - Kumsars, Indulis

AU - Stradins, Peteris

AU - Steigen, Terje K

AU - Fröbert, Ole

AU - Graham, Alastair N J

AU - Endresen, Petter C

AU - Corbascio, Matthias

AU - Kajander, Olli

AU - Trivedi, Uday

AU - Hartikainen, Juha

AU - Anttila, Vesa

AU - Hildick-Smith, David

AU - Thuesen, Leif

AU - Christiansen, Evald H

AU - NOBLE study investigators

A2 - Ravkilde, Jan

A2 - Thuesen, Leif

A2 - Andreasen, Jan Jesper

A2 - Aarøe, Jens

PY - 2016

Y1 - 2016

U2 - 10.1016/S0140-6736(16)32052-9

DO - 10.1016/S0140-6736(16)32052-9

M3 - Journal article

SN - 0140-6736

VL - 388

SP - 2743

EP - 2752

JO - The Lancet

JF - The Lancet

IS - 10061

ER -